SCHEMBL5659416

SCHEMBL5659416

O=CN(O)C(CC(=O)N1CCCN1C(=O)c1ccc(F)cc1)CC1CCCC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.37
CTSS P25774 1/20 0.37
DPP4 P27487 4/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
ATM Q13315 1/20 0.36
KMT2A Q03164 2/20 0.36
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
DPP8 Q6V1X1 3/20 0.35
DPP9 Q86TI2 3/20 0.35
DPP7 Q9UHL4 3/20 0.35
CTSL P07711 1/20 0.35
HSD11B1 P28845 1/20 0.34
DRD2 P14416 2/20 0.34
HTR2A P28223 2/20 0.34
HTR2C P28335 2/20 0.34
HTR2B P41595 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5660846 0.89 DPP4 (0.42) POLBCTSSDPP4KDM4EALDH1A1
SCHEMBL5659715 0.89 MEN1 (0.39) POLBDPP4KMT2AMEN1HSD11B1
SCHEMBL5655978 0.88 RECQL (0.38) POLBCTSSDPP4KMT2AKDM4E
SCHEMBL5656723 0.87 GRM3 (0.42) POLBALDH1A1EPHX2
SCHEMBL5659385 0.86 CTSS (0.34) POLBCTSSDPP4NPC1RAB9A
SCHEMBL5657247 0.84 ALDH1A1 (0.35) POLBCTSSDPP4NPC1RAB9A
SCHEMBL5659925 0.82 ALDH1A1 (0.48) POLBDPP4KMT2AKDM4EMEN1
SCHEMBL5657935 0.80 DPP4 (0.33) DPP4
SCHEMBL5655746 0.79 ALDH1A1 (0.46) POLBKDM4EALDH1A1DRD2HTR2A
SCHEMBL5656031 0.79 ALDH1A1 (0.41) POLBCTSSNPC1RAB9AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7192953-B2 Antibacterial agents VERNALIS (OXFORD) LIMITED (GB) 2007-03-20 US disclosed
US-20060128811-A1 Hydroxamic acid- and N-formyl hydroxylamine hydrazide derivatives; veterinary medicine VERNALIS (OXFORD) LIMITED (GB) 2006-06-15 US disclosed
EP-1567504-A1 ANTIBACTERIAL AGENTS Vernalis (Oxford) Ltd (GB) 2005-08-31 EP disclosed
WO-2004050638-A1 ANTIBACTERIAL AGENTS VERNALIS (OXFORD) LTD. (GB) 2004-06-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060128811-A1 Hydroxamic acid- and N-formyl hydroxylamine hydrazide derivatives; veterinary medicine HRH2, HCAR3, HCAR2 POLB 3054/4885CTSS 635/4885DPP4 3934/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.